Despite a relatively low CrAg prevalence in PLWH with CD4 100–200 cells/mm3, using a low-cost screening test and prophylactic fluconazole would likely be cost-effective when compared to the high costs of cryptococcal meningitis and/or mortality. This evidence concerns the gene CD4 and Cryptococcal meningitis.